Genetic Susceptibility to Critical Illnesses and Acute Organ Failure
Einstein-Montefiore Department of Medicine Grand Rounds
Thursday, November 5, 2009
First Floor Lecture Hall, Forchheimer/Einstein
Cherkasky Auditorium, Moses/Montefiore
Michelle N. Gong, MD, MS
Director of Critical Care Research
Assistant Professor, Medicine (Critical Care)
Assistant Professor, Epidemiology and Population Health
Albert Einstein College of Medicine and Montefiore Medical Center
Dr. Michelle Gong recently came to Montefiore and Einstein from the Mount Sinai School of Medicine, where she was a member of the Pulmonary and Critical Care division. A native New Yorker, she graduated from the Bronx High School of Science, located only a few blocks from Montefiore Medical Center.
Dr. Gong received a bachelor of science in engineering from the University of Pennsylvania before completing her medical degree at Yale University School of Medicine. She did her residency in internal medicine at the Beth Israel Hospital in Boston, and then remained as a clinical and research fellow in the Harvard Combined Program in Pulmonary and Critical Care Medicine. She then joined the faculty of Harvard Medical School and attended in the medical intensive care unit of the Massachusetts General Hospital. During that time, she also received a master's degree in epidemiology from the Harvard School of Public Health, and still serves as a visiting scientist in the Department of Environmental Health at the Harvard School of Public Health.
Dr. Gong's major research interest is in risk prognostication and outcomes studies of critical illnesses such as sepsis and acute respiratory distress syndrome (ARDS). She also has a special interest in better understanding the unique epidemiologic and ethical circumstances surrounding critical care research.
Dr. Gong has been a past recipient of the National Institutes of Health's (NIH) Health Disparity Scholar Award and the Mentored Patient-Oriented Research Career Development Award. She is currently the recipient of NIH-supported investigator-initiated awards to examine both the potential role of early insulin therapy to modulate lung injury in sepsis, and the special issue of surrogate consents for research in incapacitated, critically ill patients. As a physician-scientist, she has served on study sections of the NIH. She received several teaching and clinical research awards from Mount Sinai during her time there.
This grand rounds is hosted by the Division of Critical Care Medicine.
After attending this activity, participants will be able to understand the role of and the approaches used in the investigation of genetic heterogeneity and gene-environment interaction in the development of critical illnesses like sepsis and acute lung injury.
Albert Einstein College of Medicine designates this educational activity for a maximum of 1 credit towards the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the educational activity.